Related Experiment Video
Updated: Jan 9, 2026

Antigenic Liposomes for Generation of Disease-specific Antibodies
Published on: October 25, 2018
Eating away at food allergy
Yue Jennifer Du1, Jessica C Guo2, Julia E M Upton3
1Internal Medicine, DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.
Early and consistent oral exposure to allergenic foods can prevent food allergy (FA) development, even with risk factors like eczema. Current treatments include tailored avoidance and immunotherapy, with biologics aiding tolerance and potentially leading to sustained remission.
Area of Science:
- Immunology
- Public Health
- Allergy Research
Background:
- Food allergy (FA) is a growing global health issue impacting patients and healthcare systems.
- The dual-allergen hypothesis posits that early skin exposure increases sensitization, while early oral intake promotes tolerance.
- Understanding FA development and management is crucial due to its significant impact on quality of life.
Purpose of the Study:
- To review current understanding of food allergy (FA) development and management strategies.
- To explore the role of early oral food exposure in preventing FA.
- To discuss evolving treatment approaches including immunotherapy and biologics.
Main Methods:
- Literature review of current research on food allergy (FA) pathogenesis and treatment.
- Analysis of the dual-allergen hypothesis regarding exposure routes.
- Overview of available and emerging therapeutic interventions for FA.
Main Results:
- Early and sustained oral ingestion of allergenic foods can prevent FA, overriding other risk factors like eczema.
- Tailored avoidance strategies, such as using denatured milk or egg products, are now common.
- Food immunotherapy, including various routes and doses, is increasingly available, with biologics enhancing safety and tolerance.
Conclusions:
- Early oral food exposure is a key factor in preventing food allergy (FA).
- Food immunotherapy and biologics offer promising avenues for managing FA, reducing reactivity, and potentially achieving remission.
- Treatment timing, particularly during periods of low IgE formation in younger individuals, may optimize remission outcomes, while older patients can benefit from increased reactivity thresholds.
Related Concept Videos
Allergic Reactions
Allergic Drug Reactions
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Cross-reactivity
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

